CUHK Co-led Landmark Global Study Shows Over Half of Advanced ALK-positive Lung Cancer Patients Stay Progression-free at Seven Years
June 12, 2026
June 12, 2026
SHATIN, Hong Kong, June 12 (TNSjou) -- The Chinese University of Hong Kong issued the following news release:
* * *
CUHK co-led landmark global study shows over half of advanced ALK-positive lung cancer patients stay progression-free at seven years
Revealing potential to transform specific oncogene-driven lung cancer into a chronic disease
-
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) co-led . . .
* * *
CUHK co-led landmark global study shows over half of advanced ALK-positive lung cancer patients stay progression-free at seven years
Revealing potential to transform specific oncogene-driven lung cancer into a chronic disease
-
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) co-led . . .
